- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Swiss Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED Apr 23, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BANB | CHF81.15 | 1.5% | -15.0% | CHF6.1b | CHF70.80 | PE54.4x | E15.4% | 1.0% | ||
KURN | CHF7.11 | -2.9% | 490.0% | CHF262.0m | n/a | PS7.8x | n/a | n/a | ||
MOLN | CHF3.42 | 1.0% | -41.7% | CHF112.2m | CHF9.35 | PS15.9x | E5.1% | n/a | ||
LONN | CHF526.40 | 0.04% | -5.5% | CHF38.0b | CHF566.00 | PE58x | E19.9% | 0.8% | ||
DESN | CHF231.50 | -0.2% | 2.7% | CHF3.2b | n/a | PE37x | S11.2% | 0% | ||
ADXN | CHF0.14 | -22.6% | 14.8% | CHF17.4m | n/a | PS10.6x | E94.0% | n/a | ||
SKAN | CHF81.50 | -1.3% | -6.5% | CHF1.8b | CHF91.33 | PE69.6x | E34.8% | 0.4% | ||
TECN | CHF336.80 | -0.1% | -15.6% | CHF4.3b | CHF395.57 | PE32.7x | E9.2% | 0.9% | ||
COPN | CHF74.40 | 5.5% | 36.0% | CHF1.2b | CHF93.67 | PE1067x | E30.4% | 2.6% | ||
PPGN | CHF29.70 | 2.9% | 46.6% | CHF979.2m | CHF21.55 | PS3.1x | E0.07% | 0% | ||
OBSN | CHF0.0054 | 8.0% | -93.6% | CHF632.8k | n/a | PE0.09x | n/a | n/a | ||
NOVN | CHF88.94 | 4.6% | -4.5% | CHF181.5b | CHF97.99 | PE21.9x | E10.0% | 3.7% | ||
ROG | CHF229.70 | 3.7% | -18.5% | CHF185.3b | CHF281.06 | PE15.9x | E8.2% | 4.2% | ||
SFZN | CHF884.00 | -0.2% | 28.5% | CHF3.8b | CHF1,015.90 | PE33.6x | E14.7% | 0.4% |
Page 1 of 1